* Minerva Surgical Inc UTRS.OQ UTRS.O is expected
to show a
rise in quarterly revenue when it reports results on November
14.
* The Redwood City California-based company is expected to
report
a 0.8% increase in revenue to $12.6 million from $12.51 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Minerva Surgical
Inc is
for a loss of 28 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Minerva
Surgical
Inc is $5, above its last closing price of $0.28.
This summary was machine generated November 12 at 00:42 GMT.
All figures in US dollars unless otherwise stated